Akso Health (AHG) Current Deferred Revenue (2018 - 2026)

Akso Health (AHG) has reported Current Deferred Revenue for 7 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

• Quarterly Current Deferred Revenue fell 56.86% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 56.86% YoY) and the FY2026 annual result came in at $4.4 million, down 56.86% from the prior year.
• Current Deferred Revenue fell to $4.4 million in Q1 2026 per AHG's latest filing, from $8.0 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for AHG reached as high as $10.2 million in Q1 2025 and fell as low as $194376.0 in Q1 2023.
• A 4-year average of $3.9 million and a median of $3.9 million in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2025 — Current Deferred Revenue surged 2361.82% — and 2026, when it plunged 56.86%.
• Year by year, Current Deferred Revenue stood at $415020.0 in 2023, then soared by 830.86% to $3.9 million in 2024, then surged by 106.8% to $8.0 million in 2025, then slumped by 44.84% to $4.4 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.4 million, $8.0 million, and $10.2 million for Q1 2026, Q3 2025, and Q1 2025 respectively.